- Sections
- C - Chimiemétallurgie
- C07D - Composés hétérocycliques
- C07D 317/66 - Atomes d'azote ne faisant pas partie d'un radical nitro
Détention brevets de la classe C07D 317/66
Brevets de cette classe: 94
Historique des publications depuis 10 ans
|
18
|
11
|
9
|
9
|
2
|
5
|
3
|
11
|
7
|
2
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| The University of Sydney | 596 |
5 |
| Bristol-myers Squibb Company | 4878 |
4 |
| Adeka Corporation | 1363 |
4 |
| Nihon Nohyaku Co., Ltd. | 326 |
4 |
| The Regents of the University of California | 19868 |
3 |
| The Scripps Research Institute | 1349 |
3 |
| SK Biopharmaceuticals Co., Ltd. | 261 |
3 |
| Elanco Tiergesundheit AG | 419 |
3 |
| BASF SE | 20904 |
2 |
| Duke University | 3066 |
2 |
| Council of Scientific & Industrial Research | 1425 |
2 |
| Flexus Biosciences, Inc. | 13 |
2 |
| The Florida International University Board of Trustees | 610 |
2 |
| Metabasis Therapeutics, Inc. | 41 |
2 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2845 |
2 |
| The University of British Columbia | 1499 |
2 |
| Firmenich Incorporated | 148 |
2 |
| F. Hoffmann-La Roche AG | 7929 |
1 |
| Abbott Laboratories | 2406 |
1 |
| BASF Corporation | 1719 |
1 |
| Autres propriétaires | 44 |